Dr. Wolfram E. Samlowski, MD
- Medicare services, 2024
- 116,060
- Medicare patients, 2024
- 735
- Part D claims, 2024
- 828
- Publications
- 30
- Clinical trials
- 2
- Practice address
- 901 Adams Blvd, Boulder City, NV 89005
- Practice phone
- Call (702) 293-4111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Samlowski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Wolfram E. Samlowski is a hematologist and oncologist in Boulder City, Nevada
Dr. Samlowski practices at Boulder City Hospital in Boulder City, Nevada, part of Boulder City Hospital.
Dr. Samlowski's NPI, 1396810834, was assigned on November 21, 2006. Dr. Samlowski graduated from Ohio State University College of Medicine in 1978. Dr. Samlowski holds Nevada license 12318.
- NPI
- 1396810834NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779506324
- NPI enumeration date
- November 21, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (702) 293-4111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Wolfram E. Samlowski practices at Boulder City Hospital in Boulder City, Nevada
Dr. Samlowski's primary practice is Boulder City Hospital, at 901 Adams Blvd, Boulder City, NV 89005 in Clark County. The practice phone is (702) 293-4111.
- Boulder City Hospital901 Adams Blvd, Boulder City, NV 89005 · Clark CountyPhone(702) 293-4111
Source: Dmand AI Affiliation Data
Dr. Wolfram E. Samlowski is affiliated with 2 sites of care and 1 medical group
Dr. Samlowski's primary practice is Boulder City Hospital in Boulder City, Nevada, part of Boulder City Hospital. The medical group on file is Nevada Oncology Specialists. Dmand AI also links Dr. Samlowski to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Wolfram E. Samlowski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samlowski practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Boulder City Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Boulder City Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Wolfram E. Samlowski is one of 67 hematologists and oncologists in Nevada
Hematology and oncology is Dr. Samlowski's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Samlowski's licenses on file in 2 states: Nevada and Utah.
Specialties and state licenses
- Hematology and oncology, NevadaPrimary
- Utah license
Hematologists and oncologists near Dr. Samlowski
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Wolfram E. Samlowski billed Medicare for 116,060 services in 2024
CMS data shows 116,060 Medicare services from Dr. Samlowski across 72 procedure codes in 2024, for 735 Medicare patients. Medicare paid $2,747,739 for them.
Dr. Samlowski's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 63,7972024: 86,94736%
- Other services
- 2023: 15,9802024: 18,07013%
- Lab and pathology
- 2023: 5,7662024: 6,1667%
- Office and hospital visits
- 2023: 1,6592024: 1,7113%
- Tests and treatments
- 2023: 1,1992024: 1,60534%
- Surgery
- 2023: 1,2182024: 1,40315%
- Imaging
- 2023: 1382024: 15814%
Where Dr. Samlowski's Medicare services took place, 2024
- In an office115,928100%
- In a facility1320%
Dr. Samlowski compared with the Nevada median for hematologists and oncologists, 2024
- Dr. Samlowski
- Nevada median
- Medicare services
- 116,060vs 19,9005.8 times
- Medicare patients
- 735vs 60322% above
- Part D claims
- 572vs 79328% below
Medians across 67 hematologists and oncologists in Nevada with Dmand AI profiles that report each measure.
Dr. Samlowski's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Samlowski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Samlowski and other hematologists and oncologists in Nevada.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Wolfram E. Samlowski treated 735 Medicare patients in 2024, average age 75
CMS counts 735 Medicare patients who saw Dr. Samlowski in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Samlowski's median patient age at 68, with 45% women.
Dr. Samlowski's Medicare patients by age, 2024
Dr. Samlowski's Medicare patients by sex, 2024
- Women33546%
- Men40054%
Chronic conditions among Dr. Samlowski's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis44%
- Diabetes36%
- Cancer34%
- Ischemic heart disease33%
- Chronic kidney disease29%
- Anxiety24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Samlowski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women45%
- Men54%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Wolfram E. Samlowski wrote 828 Medicare Part D claims in 2024
In 2024, Dr. Samlowski wrote 828 Medicare Part D claims for 132 patients. 75% of them were for generic drugs. CMS names the drug for 572 of them, across 21 drugs with 11 or more claims each, at $652,731 in total drug cost. In 2023, CMS named 699 claims across 27 drugs.
Dr. Samlowski's Part D claims by kind of drug, 2024
- Generic623 claims75%
- Brand-name205 claims25%
Dr. Samlowski's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Samlowski's Part D claims, 2024
- Opioids6%51 of 828 claims
- Antibiotics4%31 of 828 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6992024: 57218%
Drugs named by CMS: 21 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Wolfram E. Samlowski scored 89 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Samlowski for performance year 2024, reported individually. Dr. Samlowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Samlowski's MIPS scores, performance year 2024
- 89of 100Final score
- 73.3of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Wolfram E. Samlowski has 30 publications on record
Dmand AI links 30 papers to Dr. Samlowski, published from 2011 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Melanoma, Skin Neoplasms and Ipilimumab. Dr. Samlowski has published most often in Cancer Med. Dr. Samlowski's most frequent co-authors are Mark Joshua Chang, DO, David Michael Gill and Srinivas Kiran Tantravahi, MD.
Dr. Samlowski's papers by year, 2012 to 2025
Topics Dr. Samlowski writes about most
- Melanoma
- Skin Neoplasms
- Ipilimumab
- Antineoplastic Combined Chemotherapy Protocols
- Nivolumab
- Brain Neoplasms
- Carcinoma, Renal Cell
- Disease Progression
Dr. Samlowski's most frequent co-authors
- Mark Joshua Chang, DO2 shared papers
- David Michael Gill2 shared papers
- Srinivas Kiran Tantravahi, MD2 shared papers
Recent publications by Dr. Samlowski
See who Dr. Samlowski researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Samlowski works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Wolfram E. Samlowski has worked on 2 clinical trials
Dmand AI links Dr. Samlowski to 2 clinical trials. Conditions studied include Carcinoma, Basal Cell and Neoplasms, Basal Cell. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Samlowski that name 2 trials.
Conditions in Dr. Samlowski's trials
- Carcinoma, Basal Cell
- Neoplasms, Basal Cell
Investigators on the most trials with Dr. Samlowski
- James M. Grichnik, MD2 shared trials
- Orit Markowitz2 shared trials
- Rogerio I. Neves, MD2 shared trials
Recent clinical trials with Dr. Samlowski
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Wolfram E. Samlowski received $318,488 in industry payments from 2016 to 2025
CMS Open Payments shows 456 general payments to Dr. Samlowski from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Bristol-Myers Squibb Company paid the most, $134,880. It also lists 11 research payments totaling $13,583 from 2019 to 2023, naming 2 clinical trials.
General payments to Dr. Samlowski by program year, 2016 to 2025
General payments to Dr. Samlowski by kind, 2016 to 2025
- Speaker and faculty fees$223,20270%
- Consulting fees$63,74620%
- Travel and lodging$21,0767%
- Food and beverage$10,1023%
- Education$3630%
Companies that paid Dr. Samlowski the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Wolfram E. Samlowski graduated from Ohio State University College of Medicine
Dr. Samlowski graduated from Ohio State University College of Medicine in 1978.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Wolfram E. Samlowski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Wolfram E. Samlowski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Wolfram E. Samlowski's NPI number?
Dr. Wolfram E. Samlowski's NPI number is 1396810834. It was assigned on November 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Wolfram E. Samlowski?
Dr. Wolfram E. Samlowski is a hematologist and oncologist in Boulder City, Nevada. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Wolfram E. Samlowski practice?
Dr. Samlowski practices at 901 Adams Blvd, Boulder City, NV 89005. Dr. Samlowski's primary practice is Boulder City Hospital in Boulder City, Nevada, part of Boulder City Hospital. Dmand AI also links Dr. Samlowski to 1 group practice or clinic.
What is Dr. Wolfram E. Samlowski's office phone number?
The practice phone on file for Dr. Samlowski is (702) 293-4111.
What is Dr. Wolfram E. Samlowski's medical license number?
Dr. Samlowski holds Nevada license 12318, one of the licenses on file in 2 states.
Which states has Dr. Wolfram E. Samlowski been licensed in?
Dmand AI has state licenses on file for Dr. Samlowski in Nevada and Utah.
Which hospitals is Dr. Wolfram E. Samlowski affiliated with?
Dr. Samlowski practices at Boulder City Hospital in Boulder City, Nevada.
What medical group is Dr. Wolfram E. Samlowski part of?
Dr. Samlowski is linked to Nevada Oncology Specialists.
Does Dr. Wolfram E. Samlowski accept Medicare?
Yes. CMS data shows Dr. Samlowski billed Medicare for 116,060 services in 2024, and Dr. Samlowski accepts Medicare assignment.
What is Dr. Wolfram E. Samlowski's MIPS score?
Dr. Samlowski's MIPS final score for performance year 2024 is 89 out of 100, reported individually.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Wolfram E. Samlowski see?
CMS counts 735 Medicare patients who saw Dr. Samlowski in 2024, with an average age of 75.
What services does Dr. Wolfram E. Samlowski bill to Medicare?
In 2024, Dr. Samlowski's most billed Medicare services were injected or infused drug (J9299), injected or infused drug (J9119) and injected or infused drug (J9271).
Where did Dr. Wolfram E. Samlowski go to medical school?
Dr. Samlowski graduated from Ohio State University College of Medicine in 1978.
What drugs does Dr. Wolfram E. Samlowski prescribe most?
In 2024 Medicare Part D data, Dr. Samlowski's most prescribed drugs by claims were Levothyroxine Sodium, Prednisone and Gabapentin.
Has Dr. Wolfram E. Samlowski received payments from drug or device companies?
CMS Open Payments shows $318,488 in general payments to Dr. Samlowski from 34 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Wolfram E. Samlowski been practicing?
Dr. Samlowski graduated from medical school in 1978, 48 years ago.
Does Dr. Wolfram E. Samlowski do research?
Dmand AI links 30 publications to Dr. Samlowski, published from 2011 to 2025. Dr. Samlowski has worked on 2 clinical trials.
Who does Dr. Wolfram E. Samlowski publish with?
Dr. Samlowski's most frequent co-authors are Mark Joshua Chang, DO (2 shared papers), David Michael Gill (2 shared papers) and Srinivas Kiran Tantravahi, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nevada by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card